Cargando…
Is Regenerative Medicine Ready for Prime Time in Diabetic Polyneuropathy?
PURPOSE OF REVIEW: After a prolonged warm-up period of basic research, several modalities of cell replacement therapies are under development for diseases with no available cure. Diabetic polyneuropathy (DPN) is one of the most prevalent chronic diabetes complications that causes sensorimotor dysfun...
Autores principales: | Himeno, Tatsuhito, Kamiya, Hideki, Nakamura, Jiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790837/ https://www.ncbi.nlm.nih.gov/pubmed/29383511 http://dx.doi.org/10.1007/s11892-018-0971-y |
Ejemplares similares
-
Painful and Painless Diabetic Neuropathies: What Is the Difference?
por: Shillo, Pallai, et al.
Publicado: (2019) -
Molecular Aspects in the Potential of Vitamins and Supplements for Treating Diabetic Neuropathy
por: Okdahl, Tina, et al.
Publicado: (2021) -
Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice
por: Himeno, Tatsuhito, et al.
Publicado: (2011) -
Electroencephalography functional connectivity—A biomarker for painful polyneuropathy
por: Topaz, Leah Shafran, et al.
Publicado: (2022) -
Cardiovascular health and chronic axonal polyneuropathy: A population‐based study
por: Taams, Noor E., et al.
Publicado: (2021)